Paul Glazer Buys 5.4% Stake In Post-IPO 1347 Capital Corp (TFSCU)

Paul Glazer believes 1347 Capital Corp (NASDAQ:TFSCU) is a good investment and has decided to add it to his equity portfolio. According to a recent filing with the Securities and Exchange Commission, Glazer Capital has acquired 313,000 shares, giving it control over 5.4% of the total number of shares outstanding.

1347 Capital Corp (NASDAQ:TFSCU)

1347 Capital Corp (NASDAQ:TFSCU), a blank check company, went public on July 21, in an Initial Public Offering (IPO) priced at $10.00. The company was formed with the intention of entering into a merger, exchanging shares or other similar business combinations.  A total of 4 million units were issued for gross proceedings of $40 million from the offering. Each unit comprises one share of common stock, the right to reserve one-tenth of a share on the consummation of the first business combination and one warrant to buy half a share of common stock at a fixed price of $11.50 per unit. Underwriters were offered 45-day options to buy an additional 600,000 units.

Disclosure: none.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!